Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMAD9 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | SOX12 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | ROMO1 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | TCTN3 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | VANGL2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | C7orf73 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | SFT2D3 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PDZD4 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | GPR12 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | ZIC2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |